Close

Trillium Closes US$150 Million Public Offering of Common Shares Sep 16, 2020 04:05PM
Trillium Therapeutics (TRIL) Prices 10M Share Common Offering at $13/Sh Sep 11, 2020 05:51AM
Trillium Announces Pricing of US$130 Million Public Offering of Common Shares Sep 10, 2020 08:00PM
Trillium Therapeutics (TRIL) Announces 8.5M Share Proposed Public Offering of Common Shares Sep 9, 2020 04:01PM
Trillium Announces Proposed Public Offering of Common Shares Sep 9, 2020 04:01PM
View Older Stories

Jan 29, 2020 07:00AM Trillium Closes US$117 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Jan 23, 2020 08:16AM Trillium Therapeutics (TRIL) Announces Pricing of $101.7M Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Jan 23, 2020 08:15AM Trillium Announces Pricing of US$101,700,000 Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Jan 22, 2020 04:01PM Trillium Therapeutics (TRIL) Announces Proposed Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Jan 22, 2020 04:01PM Trillium Announces Proposed Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Mar 8, 2019 06:37PM Trillium Announces Closing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
Feb 22, 2019 09:02AM Trillium Therapeutics (TRIL) Pricing of $15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
Feb 22, 2019 09:00AM Trillium Announces Pricing of US$15 Million Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
Feb 21, 2019 04:02PM Trillium Therapeutics (TRIL) to Offer Common Units and Convertible Units
Feb 21, 2019 04:00PM Trillium Announces Proposed Public Offering of Common Share Units and Series II Non-Voting Convertible First Preferred Share Units
Jun 19, 2018 06:30PM Trillium Therapeutics Announces “At-The-Market” Issuance Program and Filing of Prospectus Supplement
Feb 9, 2018 07:00AM Trillium Therapeutics to Present at Investor and Scientific Conferences in the First Quarter
Dec 1, 2017 10:21PM Trillium Announces Closing of Private Placement
Nov 15, 2017 09:18AM Trillium Therapeutics (TRIL) Reports $19.98M Private Placement
Nov 15, 2017 09:15AM Trillium Announces Private Placement
Jun 28, 2017 03:45PM Trillium Announces Partial Exercise of Over-Allotment Option
Jun 1, 2017 04:10PM Trillium Closes US$30 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
May 26, 2017 09:31AM Pre-Open Movers 05/26: (NTNX) (DECK) (WEB) Higher; (ZOES) (NAKD) (GME) Lower (more...)
May 26, 2017 08:32AM Trillium Therapeutics (TRIL) Prices 2.75M Shares at $5, Prices 3.25M Convertible Preferred Shares
May 26, 2017 08:30AM Trillium Announces Pricing of US$30.0 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preference Shares
May 25, 2017 04:03PM Trillium Therapeutics (TRIL) Plans Offering of Common Stock and Series II Non-Voting Convertible First Preferred Shares
May 25, 2017 04:01PM Trillium Announces Proposed Public Offering
Aug 3, 2016 10:41AM Notable Analyst Rating Changes 8/3: (ZNGA) (NMBL) (AVD) Upgraded; (CSIQ) (EQR) (EMR) Downgraded
Mar 8, 2016 07:00AM Trillium to Present at the Cowen and Company 36th Annual Health Care Conference
Apr 27, 2015 10:02AM UPDATE: Cowen Starts Trillium Therapeutics (TRIL) at Outperform
Apr 7, 2015 04:01PM Trillium Therapeutics Announces Completion of Public Offering of Securities
Apr 7, 2015 04:01PM Trillium Therapeutics Announces Completion of Public Offering of Securities
Apr 1, 2015 07:03AM UPDATE: Trillium Therapeutics (TRIL) Prices 1.52M Common Offering at $19.50/Share
Apr 1, 2015 07:00AM Trillium Therapeutics Announces Pricing of Public Offering of Securities
Mar 30, 2015 04:03PM Trillium Therapeutics (TRIL) Announces $50M Common Stock Offering
Mar 30, 2015 04:01PM Trillium Therapeutics Announces Proposed Public Offering of Securities
Mar 30, 2015 04:01PM Trillium Therapeutics Announces Proposed Public Offering of Securities
View Older Stories